中药防治缺血性脑卒中的药效学优势及特点

IF 4.7 4区 医学 Q1 CHEMISTRY, MEDICINAL
Hanyu Zhang , Bowen Jin , Xinyu You , Pengrong Yi , Hong Guo , Lin Niu , Qingsheng Yin , Jiangwei Shi , Yanjun Zhang , Pengwei Zhuang
{"title":"中药防治缺血性脑卒中的药效学优势及特点","authors":"Hanyu Zhang ,&nbsp;Bowen Jin ,&nbsp;Xinyu You ,&nbsp;Pengrong Yi ,&nbsp;Hong Guo ,&nbsp;Lin Niu ,&nbsp;Qingsheng Yin ,&nbsp;Jiangwei Shi ,&nbsp;Yanjun Zhang ,&nbsp;Pengwei Zhuang","doi":"10.1016/j.chmed.2023.09.003","DOIUrl":null,"url":null,"abstract":"<div><p>Ischemic stroke (IS) is a severe cerebrovascular disease with a high incidence, mortality, and disability rate. The first-line treatment for IS is the use of recombinant tissue plasminogen activator (r-tPA). Regrettably, numerous patients encounter delays in treatment due to the narrow therapeutic window and the associated risk of hemorrhage. Traditional Chinese medicine (TCM) has exhibited distinct advantages in preventing and treating IS. TCM enhances cerebral microcirculation, alleviates neurological disorders, regulates energy metabolism, mitigates inflammation, reduces oxidative stress injuries, and inhibits apoptosis, thereby mitigating brain damage and preventing IS recurrence. This article summarizes the etiology, pathogenesis, therapeutic strategies, and relationship with modern biology of IS from the perspective of TCM, describes the advantages of TCM in the treatment of IS, and further reviews the pharmacodynamic characteristics and advantages of TCM in the acute and recovery phases of IS as well as in post-stroke complications. Additionally, it offers valuable insights and references for the clinical application of TCM in IS prevention and treatment, as well as for the development of novel drugs.</p></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1674638423000862/pdfft?md5=bceca595f5e789580697ce42a581e62a&pid=1-s2.0-S1674638423000862-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Pharmacodynamic advantages and characteristics of traditional Chinese medicine in prevention and treatment of ischemic stroke\",\"authors\":\"Hanyu Zhang ,&nbsp;Bowen Jin ,&nbsp;Xinyu You ,&nbsp;Pengrong Yi ,&nbsp;Hong Guo ,&nbsp;Lin Niu ,&nbsp;Qingsheng Yin ,&nbsp;Jiangwei Shi ,&nbsp;Yanjun Zhang ,&nbsp;Pengwei Zhuang\",\"doi\":\"10.1016/j.chmed.2023.09.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Ischemic stroke (IS) is a severe cerebrovascular disease with a high incidence, mortality, and disability rate. The first-line treatment for IS is the use of recombinant tissue plasminogen activator (r-tPA). Regrettably, numerous patients encounter delays in treatment due to the narrow therapeutic window and the associated risk of hemorrhage. Traditional Chinese medicine (TCM) has exhibited distinct advantages in preventing and treating IS. TCM enhances cerebral microcirculation, alleviates neurological disorders, regulates energy metabolism, mitigates inflammation, reduces oxidative stress injuries, and inhibits apoptosis, thereby mitigating brain damage and preventing IS recurrence. This article summarizes the etiology, pathogenesis, therapeutic strategies, and relationship with modern biology of IS from the perspective of TCM, describes the advantages of TCM in the treatment of IS, and further reviews the pharmacodynamic characteristics and advantages of TCM in the acute and recovery phases of IS as well as in post-stroke complications. Additionally, it offers valuable insights and references for the clinical application of TCM in IS prevention and treatment, as well as for the development of novel drugs.</p></div>\",\"PeriodicalId\":9916,\"journal\":{\"name\":\"Chinese Herbal Medicines\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1674638423000862/pdfft?md5=bceca595f5e789580697ce42a581e62a&pid=1-s2.0-S1674638423000862-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Herbal Medicines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1674638423000862\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Herbal Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1674638423000862","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

缺血性脑卒中是一种发病率高、死亡率高、致残率高的严重脑血管疾病。IS的一线治疗是使用重组组织型纤溶酶原激活剂(r-tPA)。遗憾的是,由于狭窄的治疗窗口和相关的出血风险,许多患者遇到治疗延误。中医药在防治IS方面已显示出明显的优势。中药促进脑微循环,缓解神经系统疾病,调节能量代谢,减轻炎症,减少氧化应激损伤,抑制细胞凋亡,从而减轻脑损伤,防止IS复发。本文从中医角度综述IS的病因、病机、治疗策略及其与现代生物学的关系,阐述中医药治疗IS的优势,并进一步综述中医药在IS急性期、恢复期及脑卒中后并发症的药效学特点及优势。为中医药在IS防治中的临床应用以及新药的开发提供了有价值的见解和参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Pharmacodynamic advantages and characteristics of traditional Chinese medicine in prevention and treatment of ischemic stroke

Ischemic stroke (IS) is a severe cerebrovascular disease with a high incidence, mortality, and disability rate. The first-line treatment for IS is the use of recombinant tissue plasminogen activator (r-tPA). Regrettably, numerous patients encounter delays in treatment due to the narrow therapeutic window and the associated risk of hemorrhage. Traditional Chinese medicine (TCM) has exhibited distinct advantages in preventing and treating IS. TCM enhances cerebral microcirculation, alleviates neurological disorders, regulates energy metabolism, mitigates inflammation, reduces oxidative stress injuries, and inhibits apoptosis, thereby mitigating brain damage and preventing IS recurrence. This article summarizes the etiology, pathogenesis, therapeutic strategies, and relationship with modern biology of IS from the perspective of TCM, describes the advantages of TCM in the treatment of IS, and further reviews the pharmacodynamic characteristics and advantages of TCM in the acute and recovery phases of IS as well as in post-stroke complications. Additionally, it offers valuable insights and references for the clinical application of TCM in IS prevention and treatment, as well as for the development of novel drugs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Chinese Herbal Medicines
Chinese Herbal Medicines CHEMISTRY, MEDICINAL-
CiteScore
4.40
自引率
5.30%
发文量
629
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信